Alejandro La Greca

Alejandro La Greca

Auto-generated profile, based on publicly available information

Alejandro La Greca

INEU-CONICET, FLENI, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CAC. E. Aban
C. E. Aban
ALA. Lombardi
A. Lombardi
GNG. Neiman
G. Neiman
MBM. C. Biani
M. C. Biani
AGA. La Greca
A. La Greca
CLC. Luzzani
C. Luzzani
Epithelial to mesenchymal transition (EMT) is a critical cellular process that has been well characterized during embryonic development and cancer metastasis and it also is implicated in several physiological and pathological events including embryonic stem cell differentiation. During early stages of differentiation, human embryonic stem cells pass through EMT where deeper morphological, molecular and biochemical changes occur. Though initially considered as a decision between two states, EMT process is now regarded as a fluid transition where cells exist on a spectrum of intermediate states. In this work, using a CRISPR interference system in human embryonic stem cells, we describe a molecular characterization of the effects of downregulation of E-cadherin, one of the main initiation events of EMT, as a unique start signal. Our results suggest that the decrease and delocalization of E-cadherin causes an incomplete EMT where cells retain their undifferentiated state while expressing several characteristics of a mesenchymal-like phenotype. Namely, we found that E-cadherin downregulation induces SNAI1 and SNAI2 upregulation, promotes MALAT1 and LINC-ROR downregulation, modulates the expression of tight junction occludin 1 and gap junction connexin 43, increases human embryonic stem cells migratory capacity and delocalize β-catenin. Altogether, we believe our results provide a useful tool to model the molecular events of an unstable intermediate state and further identify multiple layers of molecular changes that occur during partial EMT.

12 January 2022 in eLife
Verified
Journal Article
Open access
AGAlejandro La Greca
Alejandro La Greca
NBNicolás Bellora
Nicolás Bellora
FDFrançois Le Dily
François Le Dily
RJRodrigo Jara
Rodrigo Jara
ANAna Silvina Nacht
Ana Silvina Nacht
PSPatricia Saragüeta
Patricia Saragüeta
Estrogen (E2) and Progesterone (Pg), via their specific receptors (ERalpha and PR), are major determinants in the development and progression of endometrial carcinomas, However, their precise mechanism of action and the role of other transcription factors involved are not entirely clear. Using Ishikawa endometrial cancer cells, we report that E2 treatment exposes a set of progestin-dependent PR binding sites which include both E2 and progestin target genes. ChIP-seq results from hormone-treated cells revealed a non-random distribution of PAX2 binding in the vicinity of these estrogen-promoted PR sites. Altered expression of hormone regulated genes in PAX2 knockdown cells suggests a role for PAX2 in fine-tuning ERalpha and PR interplay in transcriptional regulation. Analysis of long-range interactions by Hi-C coupled with ATAC-seq data showed that these regions, that we call ‘progestin control regions’ (PgCRs), exhibited an open chromatin state even before hormone exposure and were non-randomly associated with regulated genes. Nearly 20% of genes potentially influenced by PgCRs were found to be altered during progression of endometrial cancer. Our findings suggest that endometrial response to progestins in differentiated endometrial tumor cells results in part from binding of PR together with PAX2 to accessible chromatin regions. What maintains these regions open remains to be studied.

24 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AGAlejandro Damián La Greca
Alejandro Damián La Greca
NPNelba Pérez
Nelba Pérez
SCSheila Castañeda
Sheila Castañeda
PMPaula Melania Milone
Paula Melania Milone
MSMaría Agustina Scarafía
María Agustina Scarafía
SMSantiago Gabriel Miriuka
Santiago Gabriel Miriuka
Cell death experiments are routinely done in many labs around the world, these experiments are the backbone of many assays for drug development. Cell death detection is usually performed in many ways, and requires time and reagents. However, cell death is preceded by slight morphological changes in cell shape and texture. In this paper, we trained a neural network to classify cells undergoing cell death. We found that the network was able to highly predict cell death after one hour of exposure to camptothecin. Moreover, this prediction largely outperforms human ability. Finally, we provide a simple python tool that can broadly be used to detect cell death.

2 May 2025 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
RPRosana Poggio
Rosana Poggio
GRGaston A Rodriguez-Granillo
Gaston A Rodriguez-Granillo
FLFlorencia De Lillo
Florencia De Lillo
ARAlejandra Bibiana Rubilar
Alejandra Bibiana Rubilar
SGSarah Y Garron-Arias
Sarah Y Garron-Arias
SMSantiago Miriuka
Santiago Miriuka
Aims: Whole blood RNA expression is modulated in response to signals from tissues, including the vessel wall. The primary objective of this study was to explore the ability of whole blood transcriptomes, analysed using artificial intelligence (AI), to predict coronary artery calcifications (CAC). Methods and results: A total of 196 subjects [men aged 40–70 years and women aged 50–70 years without known cardiovascular disease (CVD)] were non-consecutively enrolled for CAC assessment via chest computed tomography. Whole blood RNA was isolated and sequenced. Different AI models were trained using clinical and transcriptomic variables as distinctive features to identify the presence of CAC (Agatston score >0). Finally, we compared the predictive performance of these models. The prevalence of CAC was 43.9%. The combined AI model, incorporating transcriptome data along with age, sex, body mass index, smoking status, diabetes, and hypercholesterolaemia, achieved an area under the curve (AUC) of 0.92 (95% CI, 0.88–0.95) for predicting the presence of CAC, with a sensitivity of 92%, specificity of 80%, positive predictive value of 81%, negative predictive value of 91%, and an overall accuracy of 86%. The combined AI model demonstrated significantly improved discrimination compared with the transcriptomic model (AUC 0.79; P = 0.009), the clinical variables model (AUC 0.72; P < 0.001), and the CVD risk model (AUC 0.68; P < 0.001). Conclusion: In this pilot study, an AI model integrating whole blood transcriptome data with clinical risk factors demonstrated the ability to predict CAC, providing incremental value over clinical models. Further studies are needed to achieve more robust validation.

13 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AWAriel Waisman
Ariel Waisman
FSFederico Sevlever
Federico Sevlever
DSDenisse Saulnier
Denisse Saulnier
MFMarcos Gabriel Francia
Marcos Gabriel Francia
ALAntonella Lombardi
Antonella Lombardi
SMSantiago G Miriuka
Santiago G Miriuka
Animal development relies on complex gene regulatory networks (GRNs) that govern the nearly irreversible changes that occur during cell differentiation. In this work we aimed to determine key transcription factors (TFs) associated with the dissolution of the naïve pluripotent state and the acquisition of a formative identity. We identified OCT6 as one of the earliest TFs induced during the onset of mouse embryonic stem cell (mESCs) differentiation. To investigate its role, we generated an Oct6 knockout mESC line, which failed to acquire the characteristic cell morphology associated with the formative state. Transcriptome analysis of differentiating cells revealed nearly 300 differentially expressed genes compared to wild-type cells, including pluripotency TFs Nanog, Klf2, Nr5a2, Prdm14, and Esrrb , that failed to correctly downregulate. Notably, premature expression of OCT6 in naïve cells triggered a rapid morphological transformation mirroring differentiation, accompanied by self-induction of Oct6 and expression of TFs such as Sox3, Zic2/3, Foxp1 , as well as the formative genes Dnmt3A and FGF5 . Strikingly, the majority of OCT6 expressing cells did not express NANOG. Gene expression and single molecule RNA-FISH analysis confirmed that this regulation was at the transcriptional level. Collectively, our results establish OCT6 as a key TF in the dissolution of the naïve pluripotent state and support a model where Oct6 and Nanog form a double negative feedback loop which could act as a toggle switch important for the transition to the formative state. Highlights: Oct6 is rapidly induced as mESCs exit ground state pluripotency. Loss of OCT6 negatively affects the transition to formative pluripotency. Premature expression of OCT6 in mESCs is sufficient to induce a formative-like phenotype. OCT6 and NANOG repress each other forming a double negative feedback loop.

20 August 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAlejandro La Greca
Alejandro La Greca
NBNicolás Bellora
Nicolás Bellora
FDFrançois Le Dily
François Le Dily
RJRodrigo Jara
Rodrigo Jara
JQJavier Quilez
Javier Quilez
PSPatricia Saragüeta
Patricia Saragüeta
Estrogen (E2) and Progesterone (Pg), via their specific receptors (ER and PR respectively), are major determinants in the development and progression of endometrial malignancies. Here, we have studied how E2 and the synthetic progestin R5020 affect genomic functions in Ishikawa endometrial cancer cells. Using ChIPseq in cells exposed to the corresponding hormones, we identified cell specific binding sites for ER (ERbs) and PR (PRbs), which mostly correspond to independent sites but both adjacent to sites bound by PAX2. Analysis of long-range interactions by Hi-C showed enrichment of regions co-bound by PR and PAX2 inside TADs that contain differentially progestin-regulated genes. These regions, which we call “progestin control regions” (PgCRs), exhibit an open chromatin state prior to the exposure to the hormone. Our observations suggest that endometrial response to progestins in differentiated endometrial tumor cells results in part from binding of PR together with partner transcription factors to PgCRs, compartmentalizing hormone-independent open chromatin.